Key takeaways
Zepbound doesn’t directly affect your period, but the rapid, substantial weight loss caused by the medication may change your menstrual cycle.
Sudden or significant weight loss associated with Zepbound can affect menstrual cycles in different ways — causing irregularities in some people, while helping to regulate cycles for others.
Talk to your healthcare provider if you notice persistent changes to your menstrual cycle or experience symptoms such as severe pain, extremely heavy bleeding, or three missed periods.
Here's what we'll cover
Here's what we'll cover
Here's what we'll cover
Key takeaways
Zepbound doesn’t directly affect your period, but the rapid, substantial weight loss caused by the medication may change your menstrual cycle.
Sudden or significant weight loss associated with Zepbound can affect menstrual cycles in different ways — causing irregularities in some people, while helping to regulate cycles for others.
Talk to your healthcare provider if you notice persistent changes to your menstrual cycle or experience symptoms such as severe pain, extremely heavy bleeding, or three missed periods.
If you’ve recently started using Zepbound (tirzepatide) and noticed that your period isn’t doing its usual thing, you might be wondering whether the GLP-1 is to blame. After all, many medications can cause changes to your menstrual cycle. So, does Zepbound affect your period as well?
It can — indirectly. Zepbound doesn’t directly affect your menstrual cycle. But it’s possible that the rapid and substantial weight loss often caused by the medication can play a role in messing with your period.
Keep reading to understand how and why Zepbound might cause period changes, including what you can do about it — and if you should ever worry.
Does Zepbound affect your period?
Zepbound can indirectly affect your period. It doesn’t directly target the reproductive hormones that regulate your cycle. And in clinical trials of tirzepatide (the active ingredient in Zepbound), menstrual changes weren’t identified as a side effect.
However, the significant and sudden weight loss associated with Zepbound could cause menstrual cycle changes in some people.
For example, in a survey of 1,700 users of a period-tracking app, 27% reported changes in their menstrual cycle after starting GLP-1 treatment. Analyses of Reddit posts and the Adverse Event Reporting System (FAERS) database from the US Food and Drug Administration (FDA) also surfaced some reports of period changes among people using tirzepatide (the active ingredient in Zepbound).
While these anecdotal reports don’t prove that Zepbound causes menstrual changes, they suggest it’s worth investigating further. So, let’s take a closer look at what might be going on.
How can Zepbound affect your period?
The significant weight loss that often occurs with GLP-1 medications can trigger changes in reproductive hormones and menstrual function. This can disrupt your usual flow or potentially even help to regulate it.
Here are the ways Zepbound may indirectly affect your period, and why.
Heavy bleeding
Some people have reported experiencing heavy menstrual bleeding while using Zepbound. A 2026 analysis of the FAERS database found that menstrual clots and bleeding between periods were more common with Zepbound.
Researchers have proposed that rapid fat loss may temporarily alter estrogen levels, since fat tissue both stores and produces estrogen. In theory, the breakdown of fat tissue could cause hormonal shifts that affect the uterine lining and contribute to bleeding between periods and heavier periods.
Missed periods
Losing a lot of weight, especially in a short period of time (such as on Zepbound), may lead you to skip one or more periods. Reason being, short-term weight loss of more than 10%--15% of your body weight is associated with amenorrhea, the medical term for the absence of menstruation for six months.
One potential reason why? Zepbound reduces appetite and increases feelings of fullness, leading you to eat significantly fewer calories. This prolonged calorie deficit — burning more calories than you’re taking in — can disrupt reproductive hormones essential to keeping your cycle on track.
Irregular cycles and spotting
Some people using tirzepatide also report spotting (bleeding between periods) or irregular menstrual cycles (when the number of days between periods varies a lot from month to month, or your cycle is shorter than 21 days or longer than 35).
Similar to heavier bleeding and missed periods, cycle irregularities and spotting may result from hormonal changes that occur during weight loss. This includes shifts in estrogen levels and disruptions to reproductive hormones caused by a prolonged calorie deficit.
More regular cycles
While weight loss may disrupt the menstrual cycle in some people, it can help regulate it in others. People with overweight or obesity are more likely to have heavy, irregular, infrequent, or absent periods. They’re also more likely to have PMOS (polyendocrine metabolic ovarian syndrome, formerly known as PCOS), a condition that commonly causes irregular menstrual cycles and ovulation problems.
Research suggests that even modest weight loss (2%--5% of total body weight) can improve menstrual regularity and ovulation in people with obesity and PMOS. As a result, some people who lose weight on Zepbound might find their cycles become more regular over time.
Lighter periods
Some people may notice lighter periods while on Zepbound. Although Zepbound isn’t shown to affect menstrual bleeding directly, overweight and obesity are associated with heavier periods. So, losing weight may lead to a lighter flow.
Fertility changes
Both obesity and PMOS can reduce fertility by disrupting ovulation and normal reproductive function. Research shows that losing weight may help restore more regular ovulation, potentially improving fertility.
On the other hand, if your period has gone MIA or become irregular, it could signal that ovulation isn’t occurring regularly and make conceiving more difficult. Keep in mind, it’s not recommended to use Zepbound while pregnant or trying to get pregnant. So talk to your healthcare provider before actively trying to conceive.
Can Zepbound make you miss a period?
Yes, it can — indirectly.
Zepbound, on its own, isn’t known to directly cause missed periods. However, the significant weight loss that can occur while taking Zepbound can affect the hormones involved in ovulation and menstruation. As a result, some people may experience changes in ovulation, skip a period, or even stop menstruating for several months.
Talk to your provider if you have missed your period for more than three months.
What to do if you experience period changes on Zepbound
When your period changes things up, it can be annoying (when you’re caught without the right supplies) or, honestly, disconcerting. It’s important to remember that minor menstrual changes, such as a lighter flow or a slightly shorter or longer cycle, aren’t typically a reason to worry.
Here’s how to approach any period changes you notice while on Zepbound, including when it’s worth checking with a healthcare provider.
Rule out pregnancy. Because Zepbound can impact the efficacy of oral contraceptives and because it’s not recommended to use while pregnant, you’ll want to ensure that a missed period or other menstrual changes aren’t due to pregnancy. Take a pregnancy test, and talk to your healthcare provider about the safest contraception options while you’re on Zepbound.
Check for perimenopause. If you’re in your 40s or older, menstrual changes like missed or irregular periods or flow changes can be signs of perimenopause — especially if you’re also experiencing other common symptoms like hot flashes, night sweats, or mood swings. Check with your provider to see if this might be the case.
Make sure you’re eating enough. Because Zepbound reduces appetite and causes you to eat less, there’s a risk of inadequate calorie and nutrient intake. In some cases, this may contribute to menstrual changes, including missed periods. Consult your provider or a registered dietitian for more personalized guidance to ensure your Zepbound diet is adequately supporting your health and weight loss efforts.
Track your cycle carefully. It’s a good idea to track your cycle timing and symptoms so you can stay on top of exactly which changes are happening and bring the details to your provider, if needed.
Keep an eye out for serious symptoms. Serious symptoms — like persistent or severe pelvic or abdominal pain, extremely heavy or prolonged bleeding, consistent spotting, or three missed periods in a row — should be brought to your healthcare provider in a timely manner.
Talk to your medical team. Whether or not you’re concerned about any of the cycle changes you may be noticing, it’s smart to mention them to your healthcare provider. They can help consider any other potential issues or recommend changes to your dosage, if needed.
Bottom line
Changes to your period can be frustrating or surprising, but it doesn’t necessarily mean Zepbound is causing a problem. While researchers are still working to understand exactly how medications like Zepbound can impact menstrual health, current evidence suggests that the weight loss and hormonal shifts that accompany the drug may be to blame.
Here’s what you need to know:
Zepbound doesn’t directly affect the menstrual cycle, and period changes aren’t a listed side effect of the drug — but it may have an indirect effect on your cycle.
The significant and rapid weight loss associated with Zepbound can impact reproductive hormones, potentially causing menstrual cycle changes such as spotting, irregular cycles, and lighter or heavier flows.
While minor menstrual cycle changes typically aren’t cause for concern, it’s a good idea to talk to your healthcare provider about any period changes you experience while on Zepbound, especially if you miss more than three cycles
Frequently asked questions (FAQs)
Should I stop taking Zepbound if my period changes?
No. You shouldn’t stop taking Zepbound unless you’re instructed to do so by your healthcare provider. Contact your healthcare provider right away if you are trying to conceive, become pregnant, or experience any serious side effects, such as severe stomach pain or a serious allergic reaction. They’ll help guide you from there.
At the end of the day, if you’re concerned about any period changes you’ve experienced while on Zepbound, it’s a good idea to talk to your provider.
Will my period return to normal on Zepbound?
Your period might return to normal while on Zepbound, but it isn’t guaranteed. Research specifically on tirzepatide’s impact on periods is still limited, so we can’t say for sure what its effect will be. Talk to your healthcare provider about any persistent period changes you’re noticing.
Can Zepbound cause breakthrough bleeding?
Breakthrough bleeding (i.e. spotting) wasn’t identified as a side effect in the original clinical trials of Zepbound. But it may be related to the hormonal changes that occur during significant weight loss. If you experience breakthrough bleeding for several months in a row, it’s a good idea to talk to your healthcare provider.
Does Zepbound affect hormones directly?
Yes, Zepbound can affect certain hormones directly. Here’s the deal: Zepbound mimics two hormones, GLP-1 and GIP, that help regulate blood sugar, appetite, and digestion. However, it isn’t designed to directly affect the reproductive hormones that regulate the menstrual cycle.
That said, the weight loss associated with Zepbound can affect hormone production throughout the body, potentially impacting reproductive hormone levels and menstrual patterns.
Does Zepbound affect birth control?
Yes, Zepbound can affect the efficacy of oral contraceptives (aka oral birth control pills) because it slows digestion, which can impact your body’s breakdown and absorption of the medication. People using oral contraceptives are advised to switch to a non-oral contraceptive method (e.g. IUD) or add a barrier method (e.g. condoms) for four weeks after starting Zepbound and for four weeks after each dose increase.
How much weight loss typically causes period changes?
There isn’t a specific amount of weight loss that reliably causes period changes. But factors like the speed of weight loss and size of your calorie deficit may matter more than the amount of weight you lose.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Zepbound Important Safety Information: Read more about serious warnings and safety info.
GLP-1 Important Safety Information: Read more about serious warnings and safety info.
References
American College of Obstetricians and Gynecologists. (2012). Practice Bulletin No. 128: Diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstetrics & Gynecology, 120(1), 197–206. doi: 10.1097/AOG.0b013e318262e320. Retrieved https://journals.lww.com/greenjournal/abstract/10.1097/aog.0b013e318262e320~practice-bulletin-no-128-diagnosis-of-abnormal-uterine
Caldwell, A. E., Gorczyca, A. M., Bradford, A. P., et al. (2024). Effectiveness of preconception weight loss interventions on fertility in women: a systematic review and meta-analysis. Fertility and Sterility, 122(2), 326–340. doi: 10.1016/j.fertnstert.2024.02.038. Retrieved from https://pubmed.ncbi.nlm.nih.gov/38408693/
Chen, L., Lu, Y., Zhou, Y. F., et al. (2023). The effects of weight loss-related amenorrhea on women's health and the therapeutic approaches: a narrative review. Annals of Translational Medicine, 11(2), 132. doi: 10.21037/atm-22-6366. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9929756/
Falsetti, L., Pasinetti, E., Mazzani, M. D., et al. (1992). Weight loss and menstrual cycle: clinical and endocrinological evaluation. Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology, 6(1), 49–56. doi: 10.3109/09513599209081006. Retrieved from https://pubmed.ncbi.nlm.nih.gov/1580168/
Frey, C. & Etminan, M. (2026). Association of glucagon-like peptide-1 receptor agonists with menstrual events in reproductive-aged patients. Obstetrics & Gynecology. Advance online publication. doi: 10.1097/AOG.0000000000006367. Retrieved from https://journals.lww.com/greenjournal/abstract/10.1097/aog.0000000000006367~association-of-glucagon-like-peptide-1-receptor-agonists
Garvey, W., Frias, J., Jastreboff, A., et al. (2023). Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. The Lancet, 402(10402), 613-626. doi: 10.1016/S0140-6736(23)01200-X. Retrieved from https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01200-X/
Gu, S. (2026). Adverse Events Associated with Tirzepatide: Updated Pharmacovigilance Analysis Using FAERS (2022 Q1-2025 Q1) with an Adapted Time-to-Onset Method. Drug, Healthcare and Patient Safety, 18, 556918. doi: 10.2147/DHPS.S556918. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12989282/
Jastreboff, A.M., Aronne, L.J., Ahmad, N.N., at al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. The New England Journal of Medicine, 387(3), 205–216. doi: 10.1056/NEJMoa2206038. Retrieved from https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
Loucks, A. B. & Thuma, J. R. (2003). Luteinizing Hormone Pulsatility Is Disrupted at a Threshold of Energy Availability in Regularly Menstruating Women. The Journal of Clinical Endocrinology & Metabolism, 88(1), 297-311. doi: 10.1210/jc.2002-020369. Retrieved from https://academic.oup.com/jcem/article-abstract/88/1/297/2846067
Makkena, H. B. (2026). Comparative Gynecological Safety of the Dual GIP/GLP-1 Receptor Agonist Tirzepatide vs. the GLP-1 Receptor Agonist Semaglutide: A Real-World Pharmacovigilance Analysis (2022-2025). Cureus, 18(1), e101738. doi: 10.7759/cureus.101738. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12908611/
Practice Committee of the American Society for Reproductive Medicine. (2015). Obesity and reproduction: a committee opinion. Fertility and Sterility, 104(5), 1116–1126. doi: 10.1016/j.fertnstert.2015.08.018. Retrieved from https://pubmed.ncbi.nlm.nih.gov/26434804/
Santoro, N., Roeca, C., Peters, B. A., et al. (2021). The Menopause Transition: Signs, Symptoms, and Management Options. The Journal of Clinical Endocrinology & Metabolism, 106(1), 1-15. doi: 10.1210/clinem/dgaa764. Retrieved from https://academic.oup.com/jcem/article/106/1/1/5937009?login=false
Sehgal, N. K., Tronieri, J. S., Ungar, L., et al. (2026). Self-reported side effects of semaglutide and tirzepatide in online communities. Nature Health, 1-6. doi: 10.1038/s44360-026-00108-y. Retrieved from https://www.nature.com/articles/s44360-026-00108-y
Taghavi, S. A., van Wely, M., Jahanfar, S., & Bazarganipour, F. (2021). Pharmacological and non-pharmacological strategies for obese women with subfertility. The Cochrane Database of Systematic Reviews, 3(3), CD012650. doi: 10.1002/14651858.CD012650.pub2. Retrieved from https://pubmed.ncbi.nlm.nih.gov/33765343/
Urbina, J., Salinas-Ruiz, L. E., Valenciano, C., et al. (2026). Micronutrient and Nutritional Deficiencies Associated With GLP-1 Receptor Agonist Therapy: A Narrative Review. Clinical Obesity, 16(1), e70070. doi: 10.1111/cob.70070. Retrieved from https://onlinelibrary.wiley.com/doi/abs/10.1111/cob.70070
Williams, N. I., Leidy, H. J., Hill, B. R., et al. (2014). Magnitude of daily energy deficit predicts frequency but not severity of menstrual disturbances associated with exercise and caloric restriction. American Journal of Physiology - Endocrinology and Metabolism, 308(1), E29. doi: 10.1152/ajpendo.00386.2013. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC4281686/














